Try our Advanced Search for more refined results

Lamictal Buyers Ask High Court Not To Take Antitrust Case

By Jeff Zalesin (May 2, 2016, 8:53 PM EDT) -- Buyers of the anticonvulsant drug Lamictal urged the U.S. Supreme Court on Monday to turn away GlaxoSmithKline and Teva's appeal in a pay-for-delay case, arguing lower courts rightly held that an agreement between the companies over generic versions of the drug may have been anticompetitive even if it didn't involve cash....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!